CTOs on the Move

Commonwealth Diagnostics International

www.commdx.com

 
Commonwealth Diagnostics International (CDI), Inc., was founded on the principle that preventative healthcare, including early detection and diagnosis of disease, results in expedited treatment, better patient outcomes, and robust cost savings for the healthcare delivery system. Operating out of a newly constructed laboratory in Salem, MA, CDI is an international diagnostic service provider specializing in innovative diagnostic products that assist physicians and patients with the diagnosis and management of some of the world`s most common sources of digestive distress and functional gastrointestinal disorders, including: hydrogen (H2)/methane (CH4) breath testing for Small Intestinal Bacterial Overgrowth (SIBO) and carbohydrate malabsorption, IBSchek™ for ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.commdx.com
  • 39 Norman Street
    Salem, MA USA 01970
  • Phone: 888.258.5966

Executives

Name Title Contact Details
Nathaniel Allen
 Director of Information Technology Profile

Similar Companies

Lifeclinic International, Inc.

Lifeclinic International, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Burtonsville, MD. To find more information about Lifeclinic International, Inc., please visit www.lifeclinic.com

Emergency Care Programs

Emergency Care Programs is a Brooklyn, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Associated Billing Services

Associated Billing Services is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bionor Pharma

Bionor Pharma is a leading biotechnology company advancing the first therapeutic vaccine towards a functional cure for HIV. The company`s focus is the research and development of peptide-based vaccines against viral diseases, primarily HIV. Bionor Pharma`s most advanced product candidate is Vacc-4x, which is also the most advanced therapeutic vaccine in the HIV space and has demonstrated a reduction of viral load in a large, randomized, controlled Phase II trial, as well as safety and tolerability. Pharma`s current clinical focus is to explore whether Vacc-4x, used with other medicines as a combination therapy, can reduce the viral load even further, and the company, through collaboration with Celgene, is investigating Vacc-4x and the HDAC inhibitor romidepsin in the REDUC study. In May 2015, Bionor Pharma announced promising results from an interim analysis of Part B of the REDUC study. In the study, Vacc-4x and romidepsin are explored as a possible treatment regimen to reduce the persistent latent viral reservoir in HIV infected patients on anti-retroviral treatment. Results are expected in the second half of 2015. Bionor Pharma is headquartered in Oslo, Norway, with offices in Copenhagen and New York.

Orexigen

Orexigen`s commitment to patients is reflected in all that we do: we are a company driven by the knowledge that our work is important and the desire to make a difference. Orexigen offers prospective employees exciting challenges` unique opportunities for career growth` and a fast-paced environment that emphasizes innovation and achievement.